ALKERMES | ALKS - 销售和管理费用

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	销售和管理费用	更改		日
AbbVie	USD 3.89B		325M	2025-12
Acadia Pharmaceuticals	USD 146.73M		21.82M	2025-12
ALKERMES	USD 187.2M		15.43M	2025-12
Amgen	USD 1.94B		237M	2025-12
Biogen	USD 545.2M		38.6M	2025-09
BioMarin Pharmaceutical	USD 322.21M		98.79M	2025-12
Bristol-Myers Squibb	USD 2.18B		392M	2025-12
Coherus Biosciences	USD 15M		6.26M	2025-12
Eli Lilly	USD 3.13B		391.3M	2025-12
Gilead Sciences	USD 1.78B		425M	2025-12
Heron Therapeutics	USD 23.74M		605K	2025-12
Ionis Pharmaceuticals	USD 130M		43.43M	2025-12
J&J	USD 6.03B		719M	2026-03
Malin Corporation	EUR 1.1M		400K	2024-12
Merck	USD 2.85B		215M	2025-12
Minerva Neurosciences	USD 2.48M		58.79K	2024-09
Nektar Therapeutics	USD 10.17M		10.17M	2025-12
Neurocrine Biosciences	USD 301.8M		10.2M	2025-12
Otsuka Holdings	JPY 278.3B		24.08B	2025-12
Ovoca Bio	EUR 632K		2.33M	2025-06
Pfizer	USD 4.08B		894M	2025-12
Regeneron Pharmaceuticals	USD 775M		117.2M	2025-12
Vertex Pharmaceuticals	USD 487M		41.9M	2025-12